Citation Tools
PDFOncolytic and local immunotherapy
Original research
The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a